 |
|
Neuroprotection and Immunomodulation With Mesenchymal Stem Cells in Chronic Experimental Autoimmune Encephalomyelitis
Ibrahim Kassis, MSc;
Nikolaos Grigoriadis, MD, PhD;
Basan Gowda-Kurkalli, PhD;
Rachel Mizrachi-Kol, MsC ;
Tamir Ben-Hur, MD, PhD;
Shimon Slavin, MD;
Oded Abramsky, MD, PhD;
Dimitrios Karussis, MD, PhD
Arch Neurol. 2008;65(6):753-761.
Objective To investigate the therapeutic potential of mesenchymal stromal cells (MSCs) in the chronic model of experimental autoimmune encephalomyelitis (EAE).
Design Mesenchymal stromal cells were obtained from the bone marrow of naïve C57BL and green fluorescent protein–transgenic mice and cultured with Eagle minimum essential medium/alpha medium after removal of adhering cells. Following 2 to 3 passages, MSCs were injected intraventricularly or intravenously into mice in which chronic EAE had been induced with myelin oligodendrocyte glycoprotein 35-55 peptide.
Results In 8 separate experiments, the intravenously and intraventricularly injected green fluorescent protein–positive MSCs were attracted to the areas of central nervous system inflammation and expressed galactocerebroside, O4, glial fibrillary acidic protein, and β-tubulin type III. The clinical course of chronic EAE was ameliorated in MSC-treated animals (0% mortality; mean [SE] maximal EAE score, 1.76 [1.01] and 1.8 [0.46] in the intraventricular and intravenous groups, respectively, vs 13% and 21% mortality and 2.80 [0.79] and 3.42 [0.54] mean maximal score in the controls). A strong reduction in central nervous system inflammation, accompanied by significant protection of the axons (86%-95% intact axons vs 45% in the controls) was observed in the animals injected with MSCs (especially following intraventricular administration). Mesenchymal stromal cells injected intravenously were detected in the lymph nodes and exhibited systemic immunomodulatory effects, downregulating proliferation of lymphocytes in response to myelin antigens and mitogens. Mesenchymal stromal cells cultured with fibroblast growth factor and brain-derived neurotrophic factor in vitro acquired neuronal-lineage cell morphology and expressed β-tubulin type III, nestin glial fibrillary acidic protein, and O4.
Conclusions Our results indicate that stem cells derived from bone marrow may provide a feasible and practical way for neuroprotection, immunomodulation, and possibly remyelination and neuroregeneration in diseases such as multiple sclerosis.
Author Affiliations: Department of Neurology and the Agnes-Ginges Center for Neurogenetics (Mr Kassis, Ms Mizrachi-Kol, and Drs Ben-Hur, Abramsky, and Karussis) and Department of Bone Marrow Transplantation (Drs Gowda-Kurkalli and Slavin), Hadassah-Hebrew University Hospital, Jerusalem, Israel; and Department of Neurology, AHEPA Hospital, Aristotle University, Thessaloniki, Greece (Dr Grigoriadis).
Deceased.
RELATED ARTICLE
This Month in Archives of Neurology
Arch Neurol. 2008;65(6):695-697.
FULL TEXT
|
